Entrectinib is a Pan-Trk/ROS1/ALK Inhibitor for IPF and Solid Tumor Research
Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown cause that occurs primarily in older adults. In addition, IPF is characterized by substantial…